Patient and Treatment Characteristics
| . | Newly Diagnosed . | Long-Term Survivors . |
|---|---|---|
| N | 38 | 30 |
| Demographics | ||
| Males | 25 (66) | 14 (47) |
| Females | 13 (34) | 16 (53) |
| Median age (yr) | 4.2 | 11.1 |
| Age range (yr) | 1.6-16.2 | 4.6-21.2 |
| Type of asparaginase received | ||
| E coli | 28 (74) | 30 (100) |
| PEG | 17 (45) | 7 (23) |
| Erwinia | 1 (3) | 9 (30) |
| . | Newly Diagnosed . | Long-Term Survivors . |
|---|---|---|
| N | 38 | 30 |
| Demographics | ||
| Males | 25 (66) | 14 (47) |
| Females | 13 (34) | 16 (53) |
| Median age (yr) | 4.2 | 11.1 |
| Age range (yr) | 1.6-16.2 | 4.6-21.2 |
| Type of asparaginase received | ||
| E coli | 28 (74) | 30 (100) |
| PEG | 17 (45) | 7 (23) |
| Erwinia | 1 (3) | 9 (30) |
Percentages are in parentheses.